title: OCT follow-up of systemic lupus erythematosus choroidopathy.
abstract: OBJECTIVE
  To describe ocular manifestations and particularly optical coherence tomography (OCT) findings in choroidopathy revealing a systemic lupus erythematosus, without systemic hypertension.
  
  
  METHODS
  Observational case report.
  
  
  RESULTS
  The diagnosis of systemic lupus erythematosus choroidopathy was suggested by the ocular presentation. Serous retinal detachments were confirmed using fluorescein and indocyanine green angiography. OCT was useful to monitor the regression of the serous retinal detachments. The anatomical and functional evolution was good under immunosuppressive treatment.
  
  
  CONCLUSIONS
  In this case, the choroidopathy was inaugural and signed the lupus activity. The OCT follow-up facilitated the monitoring of the efficacy of systemic medications.
authors.affiliation: Department of Ophthalmology, Grenoble University Hospital, Medical School, Joseph Fourier University, Grenoble, France.
authors.forename: Sabine
authors.initials: S
authors.lastname: Kouprianoff
authors.forename: Christophe
authors.initials: C
authors.lastname: Chiquet
authors.forename: Laurence
authors.initials: L
authors.lastname: Bouillet
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Romanet
mesh_terms: D015110:4-Hydroxycoumarins / Q000627:therapeutic use; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000792:Angiography / Q000379:methods; D000974:Antibodies, Antinuclear / Q000032:analysis; D001241:Aspirin / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D015862:Choroid Diseases / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D016903:Drug Monitoring / Q000379:methods*; D005260:Female; D019793:Fluorescein; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007192:Indenes / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D009930:Organic Chemicals; D012163:Retinal Detachment / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D041623:Tomography, Optical Coherence; D014812:Vitamin K / Q000037:antagonists & inhibitors / Q000627:therapeutic use
chemical_list: D015110:4-Hydroxycoumarins; D000305:Adrenal Cortex Hormones; D000974:Antibodies, Antinuclear; D007166:Immunosuppressive Agents; D007192:Indenes; D009930:Organic Chemicals; C011664:antivitamins K; D014812:Vitamin K; C035709:iodocyanine green; D001379:Azathioprine; D001241:Aspirin; D019793:Fluorescein